Skip to main content

Table 2 Outcomes within each primary site correlated with AJCC stage

From: Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience

 

No. of patients

5-yr LC

p-value

5-yr LRC

p-value

5-yr DFS

p-value

Oral cavity

       

   Stage III

2

50%

0.13

50%

0.13

50%

0.13

   Stage IV

16

8.1%

 

8.1%

 

8.1%

 

Oropharynx

       

   Stage III

40

68.8%

0.08

68.8%

0.01

68.8%

0.004

   Stage IV

78

53.6%

 

36.4%

 

29.5%

 

Hypopharynx

       

   Stage III

42

66.9%

0.16

59.3%

0.01

59.3%

0.009

   Stage IV

51

53.2%

 

34.4%

 

31.2%

 

Larynx

       

   Stage III

12

80.2%

0.83

80.2%

0.15

80.2%

0.07

   Stage IV

23

67.8%

 

34.3%

 

28%

 
  1. LC = local control; LRC = loco-regional control; DFS = disease-free survival